生物加工技術市場報告：2030 年趨勢、預測與競爭分析

生物製程技術趨勢與預測

到 2030 年，全球生物製程技術市場預計將達到 717 億美元，2024 年至 2030 年複合年成長率為 12.3%。該市場的主要促進因素是對下一代生物基產品的需求不斷成長以及慢性病盛行率的上升。全球生物製程技術市場的未來充滿希望，生物製藥、契約製造和學術研究市場都有機會。

Lucintel 預測，生技藥品安全測試將在預測期內達到最高成長。

在這個市場中，生物製藥預計將在預測期內實現最高成長。

預計北美地區在預測期內將出現最高的成長。

生物製程技術市場新趨勢

生物製程技術市場正在出現各種趨勢，這些趨勢將成為其未來的特徵，反映了技術進步、工業實踐的創新以及對永續性和效率的需求。相關人員需要了解所有這些，才能了解這個不斷發展的生物技術過程的前景。

• 採用連續加工：連續加工在生物加工技術中正在蓬勃發展。此過程意味著原料和產品連續流過該過程，以確保提高效率、節省成本和可擴展性。連續製程可以更好地控制和最佳化生物製程，從而提高產量並降低生產成本。
• 整合即時分析：它還能夠實現生物製程技術的轉型。可以即時監控和控制的先進感測器和資料分析工具被整合到生物製程系統中。這種趨勢可以實現更精細的控制、更快的周轉和更順暢的製程，從而提高產品品質並減少停機時間。
• 強調永續性：人們越來越重視開發永續的生物加工技術。這不僅加快了流程，還減少了與傳統方法相關的廢棄物、能源消耗和環境影響。除了應用新的綠色生物程序和綠色材料之外，永續性正在成為響應生物程序行業技術創新和法規的驅動力。
• 細胞株開發的新進展：細胞株開發的創新正在改善生物製藥和其他生物產品的生產。正在開發新技術以提高細胞株內的穩定性、生產力和一致性。這對於生物加工行業的生產擴張和高品質生產至關重要。
• 個人化醫療的發展：個人化醫療的成長趨勢正在推動生物加工技術的創新。此類治療和處理需要單獨客製化的治療並且需要專門的生物加工技術和方法。因此，更靈活、更具適應性的生物加工系統將繼續推動產業滿足個人化醫療的需求。

生物製程技術市場的未來趨勢包括連續處理、即時分析和永續性。創新和變革的其他驅動力是細胞株開發的進步和個人化醫療的發展。這些，加上效率、擴充性和環境責任的提高，為生物加工技術帶來了不同的未來。

生物製程技術市場的最新趨勢

生物加工技術市場的最新趨勢顯示一些重大進步正在改變該行業領域。新興市場的開拓意味著透過創新技術和不斷變化的需求提高效率、擴充性和永續性。

• 連續生物加工的引入：連續生物加工技術因提供效率和成本節約而越來越被接受。該技術允許連續執行生物製程，從而提供比傳統批量處理更好的製程控制、更高的產量和更快的生產時間。
• 一次性技術的發展：在快速成長的領域中，一次性技術在生物加工中的應用開始佔據主導地位。應用一次性反應器和過濾系統的主要優點包括靈活性、污染風險低和整體成本節省。事實證明，此類技術在小規模生產和快速開發週期中非常有用。
• 先進的 PAT 系統：現已整合到生物製程系統中，以增強製程監控和控制。先進的感測器和分析工具提供關鍵過程參數的即時資料，以促進製程最佳化、品管和快速解決問題。
• 綠色生物程序開發：顯然強調開發減少環境影響的綠色生物程序。已經報導了各種創新，包括節能反應器、廢棄物減少策略和可再生原料。這些發展將全球永續性目標和監管要求付諸實踐。
• 生物製藥產能擴張：生物製藥產能擴張趨勢高漲。這包括擴大生產設施，透過先進技術和自動化實現生物製藥生產規模擴大、製程最佳化和更高效率。

生物加工技術市場的最新趨勢包括連續生物加工、一次性技術和綠色生物加工。此後，這種動態導致了該行業的重大變化。透過提高效率、擴充性、環境永續性以及為生物加工技術設定新標準，進步正在重塑 CMO 格局。

生物加工技術市場的策略性成長機會

生物加工技術的成長機會正在廣泛的應用中展開，這主要是由於技術進步、對生物製藥的需求不斷增加以及對永續解決方案的推動。對於尋求利用市場趨勢實現成長的相關人員來說，識別這些機會非常重要。

• 生物製藥製造：對生物製藥的興趣和需求為生物加工技術創造了成長機會。連續加工和一次性技術可以改進生產技術並提高可擴展性，以滿足治療性蛋白質和疫苗的需求。
• 農業生物技術：生物基農藥、生物基肥料等的發展潛力大。生物加工技術的創新將進一步提高這些永續產品的生產水準。它們是化學產品的永續替代品，有助於維持環保的農業實踐。
• 環境生物修復：人們對生物處理技術在環境生物修復的應用越來越感興趣。使用微生物淨化污染物和廢棄物的更先進、更有效率的技術正在出現。因此，它為企業解決環境問題提供了新的機會，並為永續問題提供更廣泛的解決方案。
• 生物基化學品和材料：生物基化學品和材料的發展為各個行業帶來了成長機會。生物加工技術的進步正在為石化產品（例如生物分解性塑膠和生物基溶劑）的永續製造替代品鋪平道路。
• 個人化醫療的發展：生物加工技術開闢了開發特定治療方法和療法的新途徑。細胞株開發階段和生物加工技術的持續創新將繼續支持個人化醫療產品的生產並推動該領域的成長。

這些策略性成長機會包括生物製藥製造、農業生物技術、環境生物修復、生物衍生化學品和個人化醫療。這些策略性成長機會反映了生物製程技術產業的未來，該產業對永續和創新解決方案的需求量很大。

生物程序技術市場的促進因素與挑戰

影響生物加工技術市場的關鍵促進因素和挑戰包括技術、經濟和監管因素。這些對於確定行業內的成長速度、創新率和營運效率水準非常重要。一方面，技術進步推動了更有效率、更容易擴展的流程的創建和開發，而經濟因素和監管負擔則影響市場和採用率。

推動生物製程技術市場的因素包括：

1.技術改進：生物加工技術的創新，如連續加工、改進的感測器和自動化，將顯著推動市場成長。這些改進使流程更加高效、擴充性和可控，從而提高產量比率並降低生產成本。技術的進步也將使新的、更有效的生物產品的配方成為可能，以滿足製藥業和其他與環境管理相關的行業日益成長的需求。

2.生物製藥需求的成長：生物製藥需求的成長要素，包括人口老化和慢性病發病率上升等人口因素，也正在加強該產業作為生物加工技術市場的驅動力。此外，生物製藥需求需要透過生物加工技術的發展來進一步補充，以提高治療性蛋白質、疫苗和其他生技藥品的生產效率和擴充性。對高品質、具成本效益生物製藥的追求推動了生物加工技術的創造性創新和投資。

3. 強調環境永續性的法律規範將為應用於生物過程的技術提供動力。有關減少廢棄物、提高能源效率和使用可再生資源的法規促進了綠色生物製程的發展。遵守此類法規不僅符合組織制定的環境標準，還可以透過回應全球永續性要求來提供市場競爭優勢。

生物製程技術市場面臨的挑戰包括：

1. 另一個主要限制因素是營運成本高。設備、原料和營運的高成本是生物加工技術的主要挑戰。這可能會阻止小型企業進入這些行業並推廣新技術。高生產成本與生物產品的定價有關，這影響了市場競爭力和可近性。

2. 監管合規性：對於生物製程技術市場來說，管理許多複雜且嚴格的監管要求是複雜且耗時的。有關生物製藥、環境標準和安全協議的各種法規需要大量的資源和能力。由於需要時間和成本來確保滿足這些法規，產品開發和市場開拓可能會被推遲。

3.技術複雜性：生物加工技術的廣泛應用需要技術複雜性。一些依賴專業知識和技術技能的先進技術需要概念化和實施，但這並不一定適用於所有組織。因此，技術複雜性成為創新解決方案實施的瓶頸，並影響生物製程業務的效率。

在技​​術進步、對永續性的監管支持、個人化醫療的興起以及對創新者的經濟獎勵的推動下，競爭激烈的生物加工技術市場對生物製藥的需求不斷增加。另一方面，必須克服高生產成本、監管合規性和技術複雜性，才能充分發揮市場潛力。

生物製程技術（按細分市場）

本研究按產品類型、應用、最終用途和地區對全球生物加工技術進行了預測。

國家生物加工技術市場前景

由於生物技術市場的快速開拓、生物製藥需求的增加以及法規環境的變化，這個生物製程技術市場仍在經歷深刻的變化。該領域的發展正在使製藥、農業和環境管理等行業的生物過程更加高效、擴充性和永續性。美國、中國、德國、印度和日本等主要市場處於這項轉型的中心，每個市場都以自己的方式取得了有趣的進展和策略。

• 美國：總體而言，美國生物技術公司擴大利用先進的生物製程平台與即時分析相結合，以進一步提高製造效率和經濟效益。這包括創新的連續加工技術和先進的細胞培養系統，使生物製藥製造流程更加高效，並提高整體製程的可擴展性和產量。
• 中國 為了實現具有成本效益的營運，中國正在迅速增強其大規模生物加工技術的能力。最新消息涉及生物製造基礎設施投資和先進過程分析技術 - PAT 的引進。中國公司也與國際公司合作，引進最尖端科技，以提高其生物加工能力。
• 德國在將永續實踐融入生物加工技術方面處於領先地位。主要的演變是綠色生物製程的發展，最大限度地減少廢棄物產生和能源消耗。德國也投資最佳化反應器的設計和使用先進的發酵技術，提高生物技術下進行的製程的效率和環境友善性。
• 印度 印度的生物加工技術市場仍在發展中，但目標是低成本、可擴展的生物製藥生產。最近的技術進展包括一次性反應器系統的引入和微生物發酵技術的改進。印度公司也致力於加強與生物相似藥和其他高價值生物產品相關的能力，並利用這一機會來滿足國內和國際市場的需求。
• 日本 日本正在透過製程整合和自動化方面的廣泛創新實現其生物加工技術的現代化。最近的趨勢包括採用高通量篩檢技術和引入智慧生物製程系統。此外，日本主要公司正致力於利用精密生物技術開發生物基化學品和材料，這正在推動該領域的成長。

常問問題

Q1.市場規模為：

A1. 到 2030 年，全球生物製程技術市場預計將達到 717 億美元。

Q2.市場成長預測是多少：

A2. 2024年至2030年，全球生物製程技術市場預計將以12.3%的複合年成長率成長。

Q3.影響市場成長的主要促進因素是：

A3. 該市場的主要驅動力是對下一代生物基產品的需求不斷成長以及慢性病患病率的上升。

Q4.市場的主要細分市場是：

A4. 生物加工技術市場的未來充滿希望，生物製藥、契約製造和學術研究市場充滿機會。

Q5.市場的主要企業是：

A5. 生物製程技術的主要企業如下：

• Hoffmann-La Roche
• Sartorius
• Thermo Fisher Scientific
• Agilent
• ELITech

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預測，生技藥品安全測試將在預測期內達到最高成長。

Q7. 未來五年預計哪些地區的市場成長最大？

A7. 預計北美地區在預測期內成長最快。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球生物製程技術市場：市場動態

• 簡介、背景、分類
• 供應鏈
• 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

• 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
• 全球生物製程技術市場趨勢（2018-2023）與預測（2024-2030）
• 按產品類型分類的生物加工技術的全球市場
  • 生物製藥安全檢測
  • 細胞培養
  • 細胞增殖
  • 細胞株開發
  • 流式細胞技術
  • 切向流過濾
  • 流式細胞技術
• 按應用分類的全球生物加工技術市場
  • 抗生素
  • 生物相似藥
  • 重組蛋白
  • 其他
• 全球生物加工技術市場（按最終用途）
  • 生物製藥公司
  • 契約製造組織
  • 學術研究所
  • 其他

第4章 2018-2030年區域市場趨勢及預測分析

• 按地區分類的生物程序技術市場
• 北美生物製程技術市場
• 歐洲生物加工技術市場
• 亞太生物製程技術市場
• 其他區域生物加工技術市場

第5章 競爭分析

• 產品系列分析
• 業務整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 按產品類型分類的全球生物程序技術市場成長機會
  • 全球生物程序技術市場成長機會（按應用）
  • 全球生物程序技術市場成長機會（依最終用途）
  • 按地區分類的全球生物程序技術市場成長機會
• 全球生物程序技術市場的新興趨勢
• 戰略分析
  • 新產品開發
  • 擴大全球生物程序技術市場的產能
  • 全球生物程序技術市場的合併、收購和合資企業
  • 認證和許可

第7章主要企業概況

• Hoffmann-La Roche
• Sartorius
• Thermo Fisher Scientific
• Agilent
• ELITech

Bio-Process Technology Trends and Forecast

The future of the global bio-process technology market looks promising with opportunities in the biopharmaceutical, contract manufacturing organization, and academic research institute markets. The global bio-process technology market is expected to reach an estimated $71.7 billion by 2030 with a CAGR of 12.3% from 2024 to 2030. The major drivers for this market are growing demand for next-generation bio-based products and rising prevalence of chronic diseases.

Lucintel forecasts that biologics safety testing is expected to witness the highest growth over the forecast period.

Within this market, biopharmaceutical is expected to witness the highest growth over the forecast period.

North America is expected to witness highest growth over the forecast period.

Emerging Trends in the Bio-Process Technology Market

Various trends emerge in the bio-processing technology market to characterize its future, reflecting improvements in technologies, innovations in practices of industries, demands for sustainability, and efficiency. All these call for understanding on the part of the stakeholders if they ever hope to know their way around in this evolving landscape of bio-technology processes.

• Adopting Continuous Processing: In bioprocess technology, continuous processing is gaining momentum. The process means the raw material and product flow continuously through the process to ensure gains in efficiency, cost reduction, and scalability improvement. Continuous processing allows for superior control and optimization of bioprocesses-leading to higher yields and lower production costs.
• Integrating real-time analytics: will also allow the transformation of bio-process technology. Advanced sensors and data analytics tools capable of monitoring and controlling in real time are integrated with bioprocessing systems. The trend enables finer control, faster turnarounds, and a smoother process flow that results in higher product quality and less downtime.
• Sustainability Focus: There is an increasing emphasis on the development of sustainable bio-process technologies. This not only Quickens the processes but reduces wastes, energy consumption, and environmental impacts associated with conventional methods. Besides applying new green bioprocesses and eco-friendly materials, sustainability is increasingly a driver for innovation and keeping up with regulations in the bio-process industry.
• New Advances in Cell Line Development: Innovations within cell line development are improving the production of biopharmaceuticals and other bio-products. New techniques have been developed that enhance stability, productivity, and consistency within the cell line. This is quite important for scaling up production and high-quality output in the bio-process industry.
• Growth in Personalized Medicine: The increasing trend of personalized medicine drives innovation in bio-process technology. For such therapies and treatments, individually tailored therapies call for specialized bioprocessing techniques and technologies. This will continue to drive the industry towards more flexible and adaptable bio-process systems to meet the needs of personalized medicine.

Upcoming trends in the bio-process technology market include continuous processing, real-time analytics, and sustainability. The other driving forces for innovation and change are the advances in cell line development and growth in personalized medicine. These are coupled with efficiency, scalability, and environmental responsibility improvements; hence, promising a different future for bio-process technology.

Recent Developments in the Bio-Process Technology Market

Recent developments in the bio-process technology market demonstrate several key advances transforming industry segments. The developments epitomize increasing efficiency, scalability, and sustainability through innovative technologies and the evolution of market demand.

• Continuous Bioprocessing Implementation: Continuous bioprocessing technologies are increasingly gaining acceptance for bringing efficiencies and reducing costs. The technique allows for the continuous running of bioprocesses, thus offering greater process control with higher yields and faster production times than the conventional batch processing.
• Single-Use Technologies Development: Among the fastest-growing areas, the application of single-use technologies in bioprocessing is starting to prevail. The main advantages of applying single-use bioreactors and filtration systems include flexibility, low contamination risks, and overall cost decrease. Such techniques have been found useful in small-scale productions and rapid development cycles.
• Advanced PAT systems: are now integrated into bioprocessing systems to enhance process monitoring and control. Advanced sensors and analytical tools are providing real-time data on critical process parameters, thus driving better process optimization, quality control, and quicker problem resolution.
• Green Bioprocess Development: There is clear emphasis on the development of green bioprocesses that have limited environmental impact. Various innovations reported involve energy-efficient bioreactors, strategies relating to waste reduction, and renewable feedstocks. Such developments put into practice global sustainability goals and regulatory imperatives.
• Expanding Biopharmaceutical Manufacturing Capacity: There is an increasing trend towards the expansion of capacity in the manufacturing of biopharmaceuticals due to high demands. This encompasses the expansion in production facilities to achieve scale-up, process optimization, and enhancement of efficiency in manufacturing biopharmaceuticals through sophisticated technologies and automation.

Recent development within the bio-process technology market includes continuous bioprocessing, single-use technologies, and green bioprocess. The dynamics, because of this, have ever since been driving significant alteration in the industry. Advancements are improving efficiency, scalability, and environmental sustainability that reshape the CMO landscape by setting new standards for bio-process technology.

Strategic Growth Opportunities for Bio-Process Technology Market

This can be observed in the wide range of applications that the development of opportunities in bio-process technology growth has, mainly because of technological advances, increasing demand for biopharmaceuticals, and the drive toward sustainable solutions. Identification of these opportunities will be important for stakeholders, which are willing to capitalize on market trends for growth.

• Biopharmaceutical Manufacturing: Interest in and demand for biopharmaceuticals create growth opportunities in bioprocessing technology. Continuous processing and single-use technologies make production techniques better and allow companies to increase scalability with demands for therapeutic proteins and vaccines.
• Agricultural Biotechnology: Large potential is existing in the development of bio-based pesticides, bio-based fertilizers, and many others. Innovation in bio-process technology further enhances production levels for these sustainable products. These are sustainable solutions to chemical-based products that help in maintaining environmentally friendly agricultural practices.
• Environmental Bioremediation: Interest in the application of bio-process technology to environmental bioremediation is on the increase. More sophisticated and efficient technologies involved in the use of microorganisms for cleaning up pollutants and waste are arising. It therefore presents another opportunity avenue for companies to solve environmental problems and contribute toward a broader solution of sustainability issues.
• Bio-based Chemicals and Materials: The development of bio-based chemicals and materials is opening up a series of opportunities for growth in different industries. Bio-process technological advances are paving the way for sustainable manufacturing of alternatives to petrochemical-based products like biodegradable plastics and bio-based solvents.
• The growth in personalized medicine: opens up new avenues in which bio-process technology will develop specific therapies and treatments. Ongoing innovations at the cell line development stage and in bioprocessing techniques go on to continue support for the production of personalized medical products, hence driving growth in the sector.

Some of these strategic growth opportunities are in biopharmaceutical manufacturing, agricultural biotechnology, environmental bioremediation, chemicals derived from biology, and personalized medicine. Such strategic growth opportunities reflect the future of the bioprocess technology industry as one with sustainable and innovative solutions in high demand.

Bio-Process Technology Market Driver and Challenges

The major drivers and challenges affecting the bio-process technology market include technological, economic, and regulatory considerations. These have become significant in determining the pace of growth, rate of innovation, and level of operating efficiency within the industry. While on one hand, technological advancement propels the creation and development of processes that could be much more efficient and easily scaled up, the economic element and regulatory burdens affect markets and rates of adoption.

The factors responsible for driving the bio-process technology market include:

1. Technological Improvement: Innovation in bio-process technology, including continuous processing, improved sensors, and automation-a process that greatly helps spur market growth. These improvements enhance process efficiency, scalability, and control, improving yields and reducing production costs. Improved technologies further enable the formulation of new, more efficient bioproducts to meet demand from the rising pharmaceutical industry, among others related to environmental management.

2. Increase in Biopharmaceutical Demand: Growth factors of biopharmaceutical demand, including demographic factors such as an aging population and rising prevalence of chronic diseases, also enhance this segment as a driver in the bio-process technology market. Moreover, biopharmaceutical demand needs to be further complemented with the development of bioprocessing technologies in order to enhance the efficiency and scalability of manufacturing therapeutic proteins, vaccines, and other biologics. The quest for high-quality, cost-effective biopharmaceuticals furthers creative innovation and investment in bioprocess technologies.

3. The regulatory support for sustainability: supportive regulatory frameworks emphasizing environmental sustainability give momentum to the technologies applied in bio-processes. Regulations relating to waste reduction, energy efficiency, and renewable resource usage are the motivating factors in formulating green bioprocesses. Compliance with such regulations does not only meet the environmental standards set by organizations but also offers competitive advantages in the market due to the response against the call of global sustainability.

Challenges in the bio-process technology market are:

1. Another major constraint is the high operational cost. The big cost of equipment, raw materials, and operation presents a great challenge for bio-process technologies. This could prevent small companies from entering into such industries or scaling up new technologies. High production costs must relate to the pricing of bioproducts affecting the market competitiveness and accessibility.

2. Regulatory Compliance: It is complex and time-consuming for the bio-process technology market to manage a number of complex and tight regulatory requirements. The various regulations on biopharmaceuticals, environmental standards, and safety protocols require a great deal of resources and competencies. Ensuring that these regulations have been met is time-consuming and expensive, thus this could delay the development and marketing of a product.

3. Technical Complexity: The use of bio-process technologies requires great technical complexity for their widespread adoption. There is a need to conceptualize and then implement several advanced technologies that depend upon one's expertise and technical skill, which may not necessarily be available to every organization. The technological complexities, therefore, act as a bottleneck towards the implementation of innovative solutions, thus impacting efficiency in operations involving bio-processes.

The highly competitive market of bio-process technology is driven by increasing demand for biopharmaceuticals, driven by technological advancement; regulatory support for sustainability; the rise of personalized medicine; and economic incentives to innovators. On the other hand, high production costs, along with regulatory compliance and technological complexities, need to be overcome in order to realize the full potential of the market.

List of Bio-Process Technology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bio-process technology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bio-process technology companies profiled in this report include-

• Hoffmann-La Roche
• Sartorius
• Thermo Fisher Scientific
• Agilent
• ELITech

Bio-Process Technology by Segment

The study includes a forecast for the global bio-process technology by product type, application, end use, and region.

Bio-Process Technology Market by Product Type [Analysis by Value from 2018 to 2030]:

• Biologics Safety Testing
• Cell Culture
• Cell Expansion
• Cell Line Development
• Flow Cytometry
• Tangential Flow Filtration
• Flow Cytometry

Bio-Process Technology Market by Application [Analysis by Value from 2018 to 2030]:

• Antibiotics
• Biosimilars
• Recombinant Proteins
• Others

Bio-Process Technology Market by End Use [Analysis by Value from 2018 to 2030]:

• Biopharmaceutical Companies
• Contract Manufacturing Organizations
• Academic Research Institute
• Others

Bio-Process Technology Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Bio-Process Technology Market

This bio-process technology market is still subjected to serious transformation triggered by rapidly developing biotechnology, increasing demand for biopharmaceuticals, and changing regulatory environments. The developments in this field are enhancing the efficiency, scalability, and sustainability of bio-processes from industries such as pharmaceuticals, agriculture, and environmental management. Some major markets like the United States, China, Germany, India, and Japan form the hub of this transformation-they each carry some interesting advancement and strategies in their own significant way.

• United States: Automation and digitalization continue to advance in the bio-process technology market in the U.S. In general, biotechnology firms in the U.S. are increasingly using sophisticated bioprocessing platforms coupled with real-time analytics to achieve even higher efficiencies and economies in manufacturing. This includes innovative continuous processing technologies and advanced cell culture systems making the manufacturing process of biopharmaceuticals more efficient while improving the overall scalability and yield of the process.
• China: It is rapidly ramping up the capabilities of large-scale bio-process technology in China with the aim of making operations cost-effective. The latest news is about investments in biomanufacturing infrastructures and the implementation of advanced process analytical technologies-PAT. Chinese firms also partner with international companies to adopt state-of-the-art technologies in improving their bioprocessing capabilities.
• Germany: Integration of sustainable practices into bio-process technology is leading in Germany. The main evolutions have been the development of green bioprocesses to minimize the generation of waste and energy consumption. Optimizing the designs of bioreactors and using advanced fermentation technologies are also under investment in Germany, enhancing the efficiency and environmental friendliness of the processes under biotechnology.
• India: The Indian bioprocess technology market is still in development but aims to reach low-cost, scalable biopharmaceutical production. The latest technological advancements include single-use bioreactor system implementation and microbial fermentation technology improvement. Indian companies also work towards enhancing their capabilities related to biosimilars manufacturing and other high-value bioproducts, using this opportunity to fulfill the demand of domestic and international markets.
• Japan: Japan is modernizing the technology for bio-process through extensive innovation in integration of processes and automation. Few of the recent development works include the adoption of high-throughput screening technologies and the implementation of smart bioprocessing systems. Major companies in Japan are also targeting the development of bio-based chemicals and materials by using their precision biotechnology to act as the driving force behind their growth in this sector.

Features of the Global Bio-Process Technology Market

Market Size Estimates: Bio-process technology market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Bio-process technology market size by product type, application, end use, and region in terms of value ($B).

Regional Analysis: Bio-process technology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, end uses, and regions for the bio-process technology market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bio-process technology market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q1. What is the bio-process technology market size?

Answer: The global bio-process technology market is expected to reach an estimated $71.7 billion by 2030.

Q2. What is the growth forecast for bio-process technology market?

Answer: The global bio-process technology market is expected to grow with a CAGR of 12.3% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the bio-process technology market?

Answer: The major drivers for this market are growing demand for next-generation bio-based products and rising prevalence of chronic diseases.

Q4. What are the major segments for bio-process technology market?

Answer: The future of the bio-process technology market looks promising with opportunities in the biopharmaceutical, contract manufacturing organization, and academic research institute markets.

Q5. Who are the key bio-process technology market companies?

Answer: Some of the key bio-process technology companies are as follows:

• Hoffmann-La Roche
• Sartorius
• Thermo Fisher Scientific
• Agilent
• ELITech

Q6. Which bio-process technology market segment will be the largest in future?

Answer: Lucintel forecasts that biologics safety testing is expected to witness the highest growth over the forecast period.

Q7. In bio-process technology market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the bio-process technology market by product type (biologics safety testing, cell culture, cell expansion, cell line development, flow cytometry, tangential flow filtration, and flow cytometry), application (antibiotics, biosimilars, recombinant proteins, and others), end use (biopharmaceutical companies, contract manufacturing organizations, academic research institute, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
• Market Report

Table of Contents

1. Executive Summary

2. Global Bio-Process Technology Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Bio-Process Technology Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Bio-Process Technology Market by Product Type
  • 3.3.1: Biologics Safety Testing
  • 3.3.2: Cell Culture
  • 3.3.3: Cell Expansion
  • 3.3.4: Cell Line Development
  • 3.3.5: Flow Cytometry
  • 3.3.6: Tangential Flow Filtration
  • 3.3.7: Flow Cytometry
• 3.4: Global Bio-Process Technology Market by Application
  • 3.4.1: Antibiotics
  • 3.4.2: Biosimilars
  • 3.4.3: Recombinant Proteins
  • 3.4.4: Others
• 3.5: Global Bio-Process Technology Market by End Use
  • 3.5.1: Biopharmaceutical Companies
  • 3.5.2: Contract Manufacturing Organizations
  • 3.5.3: Academic Research Institute
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Bio-Process Technology Market by Region
• 4.2: North American Bio-Process Technology Market
  • 4.2.1: North American Bio-Process Technology Market by Product Type: Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration, and Flow Cytometry
  • 4.2.2: North American Bio-Process Technology Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute, and Others
• 4.3: European Bio-Process Technology Market
  • 4.3.1: European Bio-Process Technology Market by Product Type: Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration, and Flow Cytometry
  • 4.3.2: European Bio-Process Technology Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute, and Others
• 4.4: APAC Bio-Process Technology Market
  • 4.4.1: APAC Bio-Process Technology Market by Product Type: Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration, and Flow Cytometry
  • 4.4.2: APAC Bio-Process Technology Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute, and Others
• 4.5: ROW Bio-Process Technology Market
  • 4.5.1: ROW Bio-Process Technology Market by Product Type: Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration, and Flow Cytometry
  • 4.5.2: ROW Bio-Process Technology Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Bio-Process Technology Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Bio-Process Technology Market by Application
  • 6.1.3: Growth Opportunities for the Global Bio-Process Technology Market by End Use
  • 6.1.4: Growth Opportunities for the Global Bio-Process Technology Market by Region
• 6.2: Emerging Trends in the Global Bio-Process Technology Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Bio-Process Technology Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bio-Process Technology Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Hoffmann-La Roche
• 7.2: Sartorius
• 7.3: Thermo Fisher Scientific
• 7.4: Agilent
• 7.5: ELITech